Abrdn PLC Jazz Pharmaceuticals PLC Transaction History

Abrdn PLC

$53.3 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$103.94 - $118.98 $1.3 Million - $1.49 Million	-12,526 Reduced 22.3%	43,636 $4.66 Million
Q1 2024 May 08, 2024	SELL	$115.19 - $132.77 $7,832 - $9,028	-68 Reduced 0.12%	56,162 $6.76 Million
Q4 2023 Jan 31, 2024	BUY	$114.26 - $136.0 $5.24 Million - $6.24 Million	45,860 Added 442.24%	56,230 $6.92 Million
Q3 2023 Nov 06, 2023	SELL	$122.0 - $145.31 $2.74 Million - $3.26 Million	-22,453 Reduced 68.41%	10,370 $1.34 Million
Q2 2023 Jun 20, 2024	BUY	$122.5 - $147.16 $308,822 - $370,990	2,521 Added 8.32%	32,823 $4.07 Million
Q2 2023 Aug 04, 2023	BUY	$122.5 - $147.16 $308,822 - $370,990	2,521 Added 8.32%	32,823 $4.07 Million
Q1 2023 Jun 20, 2024	BUY	$133.98 - $160.47 $991,050 - $1.19 Million	7,397 Added 32.29%	30,302 $4.43 Million
Q1 2023 Apr 28, 2023	BUY	$133.98 - $160.47 $991,050 - $1.19 Million	7,397 Added 32.29%	30,302 $4.43 Million
Q4 2022 Jun 20, 2024	SELL	$129.72 - $159.85 $4.31 Million - $5.32 Million	-33,257 Reduced 59.22%	22,905 $3.65 Million
Q4 2022 Feb 09, 2023	BUY	$129.72 - $159.85 $202,492 - $249,525	1,561 Added 7.31%	22,905 $3.65 Million
Q3 2022 Nov 10, 2022	BUY	$126.59 - $161.18 $2.07 Million - $2.64 Million	16,368 Added 328.94%	21,344 $2.85 Million
Q2 2021 Aug 10, 2021	SELL	$160.2 - $186.42 $139,213 - $161,998	-869 Reduced 14.87%	4,976 $884,000
Q1 2021 May 06, 2021	SELL	$150.19 - $173.5 $30,338 - $35,047	-202 Reduced 3.34%	5,845 $961,000
Q4 2020 Feb 10, 2021	SELL	$140.71 - $165.05 $21,247 - $24,922	-151 Reduced 2.44%	6,047 $998,000
Q3 2020 Oct 21, 2020	SELL	$105.46 - $144.13 $833,134 - $1.14 Million	-7,900 Reduced 56.04%	6,198 $885,000
Q2 2020 Aug 10, 2020	SELL	$95.68 - $121.88 $1.45 Million - $1.85 Million	-15,185 Reduced 51.86%	14,098 $1.56 Million
Q1 2020 May 13, 2020	SELL	$87.74 - $152.74 $243,215 - $423,395	-2,772 Reduced 8.65%	29,283 $2.93 Million
Q4 2019 Feb 18, 2020	BUY	$117.65 - $153.73 $1.17 Million - $1.53 Million	9,934 Added 44.91%	32,055 $4.79 Million
Q3 2019 Nov 13, 2019	BUY	$125.18 - $143.24 $485,322 - $555,341	3,877 Added 21.25%	22,121 $2.83 Million
Q2 2019 Aug 13, 2019	SELL	$125.55 - $144.48 $53,484 - $61,548	-426 Reduced 2.28%	18,244 $2.6 Million
Q1 2019 May 14, 2019	BUY	$121.81 - $142.95 $1.82 Million - $2.14 Million	14,972 Added 404.87%	18,670 $2.67 Million
Q4 2018 Feb 12, 2019	SELL	$115.94 - $166.74 $3,826 - $5,502	-33 Reduced 0.88%	3,698 $449,000
Q3 2018 Nov 13, 2018	SELL	$161.01 - $180.57 $26,566 - $29,794	-165 Reduced 4.24%	3,731 $627,000
Q2 2018 Aug 09, 2018	BUY	$146.33 - $183.18 $570,101 - $713,669	3,896 New	3,896 $671,000

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account